VI
GBT

Vestcor Inc’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Vestcor Inc’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-62,286
Closed -$4.24M – 1492
2022
Q3 		$4.24M Buy
+62,286
New +$3.43M 0.16% 142

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Vestcor Inc's GBT Position: Q4 2022 in Review

Vestcor Inc sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 62,286 shares — an estimated $4.24M sold.

Vestcor Inc first reported a position in GBT in Q3 2022 and held it in 1 quarter. The position peaked at $4.24M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • Vestcor Inc reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • Vestcor Inc sold 62,286 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $4.24M.
  • Vestcor Inc first reported a position in Global Blood Therapeutics, Inc. in Q3 2022 and held it in 1 quarter.
  • Vestcor Inc's Global Blood Therapeutics, Inc. position peaked at $4.24M in Q3 2022.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Vestcor Inc's 13F filing for Q4 2022, filed 15 Feb 2023.